Esprit BTK Device

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

Critical Limb Ischemia (CLI)

Unknown Phase

LIFE-BTK Randomized Controlled Trial

Active, not recruitingNCT04227899

Abbott Medical DevicesCritical Limb Ischemia (CLI)

Start: 2020-08-18End: 2027-07-31Updated: 2025-12-30

LIFE-BTK PK Sub-study

Active, not recruitingNCT05208905

Abbott Medical DevicesCritical Limb Ischemia (CLI)

Start: 2022-02-10End: 2028-02-22Updated: 2026-01-26

Related Papers

Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK Trial.

2026-05-13

Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial

Circulation2025-09-105 citations

Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease

New England Journal of Medicine2023-10-2596 citations